Cargando…

CM from intact hAM: an easily obtained product with relevant implications for translation in regenerative medicine

BACKGROUND: It is now well established that factors (free or in extracellular vesicles) secreted by mesenchymal stromal cells (MSC) are important mediators of MSC regenerative actions. Herein we produced the secretome (conditioned medium, CM) from MSC isolated from the amniotic membrane (hAMSC) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silini, Antonietta Rosa, Papait, Andrea, Cargnoni, Anna, Vertua, Elsa, Romele, Pietro, Bonassi Signoroni, Patrizia, Magatti, Marta, De Munari, Silvia, Masserdotti, Alice, Pasotti, Anna, Rota Nodari, Sara, Pagani, Giorgio, Bignardi, Mario, Parolini, Ornella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513276/ https://www.ncbi.nlm.nih.gov/pubmed/34641958 http://dx.doi.org/10.1186/s13287-021-02607-z

Ejemplares similares

Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective
por: Papait, Andrea, et al.
Publicado: (2022)

Amniotic MSCs reduce pulmonary fibrosis by hampering lung B‐cell recruitment, retention, and maturation
por: Cargnoni, Anna, et al.
Publicado: (2020)

B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells
por: Magatti, Marta, et al.
Publicado: (2020)

Human amniotic mesenchymal stromal cells support the ex vivo expansion of cord blood hematopoietic stem cells
por: Orticelli, Valentina, et al.
Publicado: (2021)

The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin
por: Magatti, Marta, et al.
Publicado: (2018)

Perinatal Mesenchymal Stromal Cells and Their Possible Contribution to Fetal-Maternal Tolerance
por: Magatti, Marta, et al.
Publicado: (2019)

The Role of B Cells in PE Pathophysiology: A Potential Target for Perinatal Cell-Based Therapy?
por: Magatti, Marta, et al.
Publicado: (2021)

Extracellular Vesicles From Perinatal Cells for Anti-inflammatory Therapy
por: Cargnoni, Anna, et al.
Publicado: (2021)

Effect of human amniotic epithelial cells on pro‐fibrogenic resident hepatic cells in a rat model of liver fibrosis
por: Cargnoni, Anna, et al.
Publicado: (2017)

The Multifaceted Roles of MSCs in the Tumor Microenvironment: Interactions With Immune Cells and Exploitation for Therapy
por: Papait, Andrea, et al.
Publicado: (2020)

Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine
por: Papait, Andrea, et al.
Publicado: (2020)

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as healthy controls
por: Pianta, Stefano, et al.
Publicado: (2015)

Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest
por: Magatti, Marta, et al.
Publicado: (2012)

The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine
por: Silini, Antonietta R., et al.
Publicado: (2015)

Disclosing the molecular profile of the human amniotic mesenchymal stromal cell secretome by filter-aided sample preparation proteomic characterization
por: Muntiu, Alexandra, et al.
Publicado: (2023)

Shaping the Future of Perinatal Cells: Lessons From the Past and Interpretations of the Present
por: Silini, Antonietta R., et al.
Publicado: (2019)

The Cells and Extracellular Matrix of Human Amniotic Membrane Hinder the Growth and Invasive Potential of Bladder Urothelial Cancer Cells
por: Ramuta, Taja Železnik, et al.
Publicado: (2020)

Human amnion favours tissue repair by inducing the M1‐to‐M2 switch and enhancing M2 macrophage features
por: Magatti, Marta, et al.
Publicado: (2016)

Amniotic Membrane-Derived Stromal Cells Release Extracellular Vesicles That Favor Regeneration of Dystrophic Skeletal Muscles
por: Sandonà, Martina, et al.
Publicado: (2023)

Perinatal Cells: A Promising COVID-19 Therapy?
por: Papait, Andrea, et al.
Publicado: (2021)

Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study
por: Bonomi, Arianna, et al.
Publicado: (2015)

Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells
por: Lange-Consiglio, Anna, et al.
Publicado: (2020)

Systemic immune response in young and elderly patients after traumatic brain injury
por: Magatti, Marta, et al.
Publicado: (2023)

Amniotic Membrane Mesenchymal Cells-Derived Factors Skew T Cell Polarization Toward Treg and Downregulate Th1 and Th17 Cells Subsets
por: Pianta, Stefano, et al.
Publicado: (2014)

Immunological and Differentiation Properties of Amniotic Cells Are Retained After Immobilization in Pectin Gel
por: Silini, Antonietta R., et al.
Publicado: (2018)

Mapping of the Human Placenta: Experimental Evidence of Amniotic Epithelial Cell Heterogeneity
por: Centurione, Lucia, et al.
Publicado: (2018)

Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease
por: Giampà, Carmela, et al.
Publicado: (2018)

Fight the Cancer, Hit the CAF!
por: Papait, Andrea, et al.
Publicado: (2022)

Placental Cells and Derivatives: Advancing Clinical Translation
por: Silini, Antonietta R., et al.
Publicado: (2018)

Internalization of nanopolymeric tracers does not alter characteristics of placental cells
por: Bigini, Paolo, et al.
Publicado: (2016)

Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis
por: Cargnoni, Anna, et al.
Publicado: (2012)

Amniotic membrane‐mesenchymal stromal cells secreted factors and extracellular vesicle‐miRNAs: Anti‐inflammatory and regenerative features for musculoskeletal tissues
por: Ragni, Enrico, et al.
Publicado: (2021)

Editorial: Perinatal Derivatives and the Road to Clinical Translation, Volume I
por: Silini, Antonietta R., et al.
Publicado: (2021)

Editorial: MSC-Derived Extracellular Vesicles and Secreted Factors as “Cell-Free” Therapeutic Alternatives in Regenerative Medicine
por: Ragni, Enrico, et al.
Publicado: (2022)

Editorial: Perinatal derivatives and the road to clinical translation, Volume II
por: Silini, Antonietta R., et al.
Publicado: (2022)

Characterization of the Conditioned Medium from Amniotic Membrane Cells: Prostaglandins as Key Effectors of Its Immunomodulatory Activity
por: Rossi, Daniele, et al.
Publicado: (2012)

Gestational stage affects amniotic epithelial cells phenotype, methylation status, immunomodulatory and stemness properties
por: Barboni, Barbara, et al.
Publicado: (2014)

Nano-Immunomodulation: A New Strategy for Skeletal Muscle Diseases and Aging?
por: Millozzi, Francesco, et al.
Publicado: (2023)

Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues
por: Kmiecik, Gabriela, et al.
Publicado: (2014)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tmorcihl2mvg1nd2j1pg3dioev